Company Overview and News
HONG KONG, Aug 22 (Reuters) - AAC Technologies Holdings Inc , an acoustic components supplier to Apple Inc , said on Thursday quarterly net profit declined for the first time in nearly four years, bruised by a sluggish smartphone market.
AAPL AACAY AACAF
As fall approaches, Apple fans are rubbing their hands together at the prospect of refreshed iPhones, upgraded MacBooks, iPad Pros and a fourth series of Apple Watches; and Bloomberg says those dreams are coming true.
Tech stocks have served as the backbone of market growth in many respects. Not only has the tech industry boomed but technology has fundamentally reshaped other industries such as retail, media and transportation. But many companies at the center of this tech boom may have run too high too fast, leading to very high(P/E) ratios. And investors should be checking their portfolios for overvalued tech stocks.
INTU SQ AMZN NOW AAPL CSCO PYPL NFLX INTC DIS WMT
We’re halfway through 2018, and all the major market indices are beginning to rumble with breakout potential. Since mid-June, the S&P 500 is up roughly 7%, but only about 4% since the start of the year. But led by double-digit performances by Nike (NYSE:NKE), Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) in the Dow Jones, and 80%, 90% and 200% gains from the S&P’s best stocks to buy, the market is on the verge of shedding 2018’s correction.
STZ.B DISCB DISCA ULTA TWX STZ GOOG DISCK TWC FEYE AMZN NKE T GOOGL GRMN AAPL MSFT TXT DLX DISC
Roku (NASDAQ:ROKU) saw its stock rocket higher last week as the company beat both earnings and revenue estimates. The stock, which has traded as low as $15.75 per share in the previous year, has reached highs exceeding $60 per share following the earnings beat.
AMZN GOOGL ROKU AAPL GOOG
7h seekingalpha - 1
Nvidia's CEO once declared Tesla's autopilot as 5 years ahead of everyone when they selected their technology. Now, NVDA is being replaced by a seemingly basic in-house custom inference accelerator.
GOOGL AAPL TSLA NVDA GOOG GM INTC BIDU
Apple (NASDAQ:AAPL) recently made stock market history. It beat all the challengers, topping Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG), and other potential rivals to the crown. The prize? AAPL stock recently became the first equity in American history to sport a market capitalization of $1 trillion.
IBM GE GEC AMZN XOM GOOGL AAPL GNE GOOG
At the end of July, Shopify (NYSE:SHOP) reported its fiscal second-quarter results. The company beat on both earnings-per-share and revenue expectations, turning a surprise profit in the process. However, it wasn’t enough to propel SHOP stock back to its prior highs.
SHOP GOOGL AAPL MSFT GOOG
It’s smelling like roses these days, but technically speaking Apple (NASDAQ:AAPL) is ripe for turning less sweet with investors. Yet, if you’re an agreeable bull hunting for a way to position in AAPL, an out-of-the-money put spread is the (risk-adjusted) move to make. Let me explain.
Don’t misread the message. Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) still effectively “owns” the internet, with its Google arm facilitating 86% of the world’s web searches. And, GOOGL stock has been one of the market’s most reliable winners for investors willing to stick with it for the long haul.
FOX CMCSA TWX NFLX GOOG TWC AMZN T GOOGL ROKU AAPL FOXA DIS
2017-10-15 - Asif
Apple, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company’s products and services include iPhone®, iPad®, Mac®, Apple Watch®, Apple TV®, a portfolio of consumer and professional software applications, iOS, macOS®, watchOS® and tvOS™ operating systems, iCloud®, Apple Pay® and a variety of accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store®, App Store®, Mac App Store, TV App Store, iBooks Store® and Apple Music® (collectively “Digital Content and Services”). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple...
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET